Anzeige
Mehr »
Freitag, 22.05.2026 - Börsentäglich über 12.000 News
Am 24. Mai wird es explosiv: +40% Kursgewinn in 5 Tagen: Eskaliert diese Nasdaq-Aktie jetzt komplett?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Renaissance Capital

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
01.05.Neuropsychiatric therapeutics Seaport Therapeutics prices upsized IPO at $18, the high end of the range
01.05.Renaissance Capital's April IPO Market Update
01.05.SPAC Quantum Leap Acquisition prices $200 million IPO, targeting AI, quantum computing, and blockchain
01.05.SPAC CH4 Natural Solutions prices $200 million IPO, targeting businesses with real-asset footprints
01.05.Hemab Therapeutics prices upsized IPO at $18, the high end of the range
30.04.Ammunition manufacturer First Breach files for a direct listing on the Nasdaq
30.04.Exploration-stage mining company Silver Bow Mining prices upsized IPO at the $11.50 midpoint
30.04.Coagulation disorder biotech Hemab Therapeutics Holdings ups shares offered by 27% ahead of $255 million IPO
30.04.SPAC Forefront Tech Holdings Acquisition prices $100 million IPO, targeting AI and robotics
30.04.SPAC General Catalyst Global Resilience Merger prices $350 million IPO, targeting aerospace and defense
30.04.SPAC Mountain Crest Acquisition 6 prices $60 million IPO, led by Suying Liu
30.04.SPAC West Enclave Merger prices $100 million IPO, targeting Latin America-focused businesses
30.04.Pulmonary fibrosis biotech Avalyn Pharma prices upsized IPO at $18, the high end of the range
30.04.SPAC GSR V Acquisition files for a $200 million IPO, targeting companies with leading market positions
29.04.SPAC Aussie Aussie Acquisition files for a $100 million US IPO, targeting defensible market positions
29.04.Pulmonary fibrosis biotech Avalyn Pharma increases shares offered by 41% ahead of $283 million IPO
29.04.Bill Ackman's closed-end fund Pershing Square USA prices $5 billion IPO at $50 per share; manager Pershing Square Inc. also set to trade on the NYSE
29.04.IPO Weekly Weigh-in: Kraken's pre-IPO haircut?
29.04.SPAC Collective Acquisition II prices $220 million IPO, targeting finance, defense technology, and AI
28.04.Malaysian fintech AsiaFIN Holdings revises terms, changes underwriter ahead of $19 million US IPO
28.04.Exploration-stage mining company Rare Earths Americas sets terms for $50 million IPO
28.04.SPAC Plutonian Acquisition II prices $100 million IPO, targeting energy storage and telecom
28.04.Michael Klein's SPAC Churchill Capital XII prices upsized $360 million IPO
28.04.Aerospace and defense-focused SPAC Irenic Acquisition prices $220 million IPO
27.04.Japanese auto software developer Micware decreases ADSs offered by nearly 50% ahead of $17 million US IPO